2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-2-methyl-3-oxo-1-phenylpropyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

Metabolite details

Identifier

ZJLIGSUNHXUEKY-UHFFFAOYSA-N

InChI Key

ZJLIGSUNHXUEKY-UHFFFAOYSA-N

IUPAC name

2-amino-5-[[1-(carboxymethylamino)-3-(2-hydroxy-2-methyl-3-oxo-1-phenylpropyl)sulanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

Preferred name

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-2-methyl-3-oxo-1-phenylpropyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

INN name

—

Synonym

—

ChEBI

CHEBI:193896

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47